Bio-Rad Laboratories, Inc. BIO.B Interest received from investments
Interest received from investments at other companies
Other financials
Where this comes from
Reported directly by Bio-Rad Laboratories, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromOtherOperatingActivities.
The official record: Bio-Rad Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Rad Laboratories, Inc.'s interest received from investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Rad Laboratories, Inc.'s interest received from investments?
- Bio-Rad Laboratories, Inc. (BIO.B) reported interest received from investments of $33.3M in Q1 2026.
- How has Bio-Rad Laboratories, Inc.'s interest received from investments changed year-over-year?
- Bio-Rad Laboratories, Inc.'s interest received from investments increased by 104.3% year-over-year, from $16.3M to $33.3M.
- What is the long-term trend for Bio-Rad Laboratories, Inc.'s interest received from investments?
- Over 4 years (2021 to 2025), Bio-Rad Laboratories, Inc.'s interest received from investments has grown at a 23.1% compound annual growth rate (CAGR), from $35.28M to $81M.
- What does interest received from investments mean?
- Cash received from non-core operating activities like interest on cash holdings.
- How do you interpret interest received from investments?
- An increase reflects higher returns on idle cash or secondary revenue streams, contributing positively to overall operating cash flow.
- How does interest received from investments compare across companies?
- Usually a minor component of cash flow; peers with large cash balances will naturally report higher interest income.